Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-26 @ 10:58 AM
Ignite Modification Date:
2025-12-26 @ 10:58 AM
NCT ID:
NCT01465906
Brief Summary:
Phrase: IV
Indication: dyspnea symptom of chronic obstructive pulmonary disease (COPD)
Objective: to evaluate efficacy and safety of tulobuterol patch combined with Tiotropium bromide for relieving dyspnea symptom of COPD
Design: a multi-centre randomized parallel blank control study
Case number: test group 80, control group 80, totally 160
Site number:7
Study period: 2010.9 - 2011.8
Study:
NCT01465906
Study Brief:
Protocol Section:
NCT01465906